logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
13/05/2025
The Nikkei index futures opened 1005 points higher at 38705 points on the Singapore Exchange.
Latest
2 m ago
Has the progress been made in the "production reduction and price support" in the silicon material sector? Industry insiders: Leading silicon material enterprises have basically reached a consensus.
4 m ago
Spring sowing enters peak period, spring sown grains in Northeast China have reached nearly 30%.
5 m ago
Midea Wandon and Brazil's VMI Group reach significant cooperation agreement.
6 m ago
Manus responds to open registration: overseas users have been removed from the waiting list, domestic products have not yet been released.
9 m ago
According to CCTV news, on the local time of the 12th, President Trump of the United States signed an executive order requiring pharmaceutical companies to lower the pricing of prescription drugs in the United States to be aligned with other developed countries. Trump claimed that drug prices should decrease by at least 59% and in some cases the reduction should reach 80% to 90%. Analysis suggests that the excessively high drug prices in the United States are due to structural reasons. If European Union companies refuse to adjust drug prices, US tariff measures may lead to trade disputes and even exacerbate drug shortages.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.